ADRA2A anticorps (AA 223-256)

N° du produit ABIN6242769

Détail du produit anti-ADRA2A anticorps

Antigène: ADRA2A (Alpha-2A Adrenergic Receptor (ADRA2A))

Épitope: AA 223-256

Reactivité: Poisson zèbre (Danio rerio)

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ADRA2A est non-conjugé

Application: Western Blotting (WB)

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This DANRE adra2a antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 223-256 amino acids from the Central region of DANRE adra2a.

Clone: RB52053

Isotype: Ig Fraction

Information d'application

Indications d'application: WB: 1:2000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Date de péremption: 6 months

Détails sur ADRA2A

Antigène: ADRA2A (Alpha-2A Adrenergic Receptor (ADRA2A))

Autre désignation: adra2a (ADRA2A Produits)

Synonymes: anticorps ADRA2A, anticorps AW122659, anticorps Adra-2, anticorps Adra-2a, anticorps alpha(2A)AR, anticorps alpha2-C10, anticorps alpha2A, anticorps alpha2A-AR, anticorps ADRA2, anticorps ADRA2R, anticorps ADRAR, anticorps ALPHA2AAR, anticorps ZNF32, anticorps CA2-47, anticorps RATRG20, anticorps RG20, anticorps PORA2AR, anticorps adrenoceptor alpha 2A, anticorps alpha-2A adrenergic receptor-like, anticorps adrenergic receptor, alpha 2a, anticorps adra2a, anticorps ADRA2A, anticorps LOC100414445, anticorps Adra2a

Sujet: Alpha-2 adrenergic receptors mediate the catecholamine- induced inhibition of adenylate cyclase through the action of G proteins. The order of potency for this receptor is dexmedetomidine > oxymetazoline = epinephrine > norepinephrine.

Poids moléculaire: 43997

UniProt: Q90WY4

Pathways: EGFR Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Negative Regulation of Transporter Activity